Key Financials (₹ in lakhs)

Income Statement

  • Total Income: ₹12,823.04 lakhs for Q1 FY27, compared to ₹10,867.16 lakhs in Q1 FY26 (18.0% increase) and ₹12,800.02 lakhs in Q4 FY26.
  • Revenue from Operations: ₹12,620.43 lakhs for Q1 FY27, compared to ₹10,710.86 lakhs in Q1 FY26 (17.8% increase) and ₹12,637.18 lakhs in Q4 FY26.
  • Other Income: ₹202.61 lakhs for Q1 FY27, compared to ₹156.30 lakhs in Q1 FY26 and ₹162.84 lakhs in Q4 FY26.

Expenses

  • Total Expenses: ₹11,106.57 lakhs for Q1 FY27, compared to ₹9,755.80 lakhs in Q1 FY26 (13.9% increase) and ₹11,213.54 lakhs in Q4 FY26.
  • Cost Breakdown:
  • Cost of materials consumed: ₹2,414.86 lakhs
  • Employee benefits expense: ₹2,323.69 lakhs
  • Finance costs: ₹216.27 lakhs
  • Depreciation and amortization: ₹688.09 lakhs
  • Other expenses: ₹5,463.66 lakhs

Profitability

  • Profit Before Tax: ₹1,716.47 lakhs for Q1 FY27, compared to ₹1,111.36 lakhs in Q1 FY26 (54.4% increase) and ₹1,586.48 lakhs in Q4 FY26.
  • Tax Expense: ₹443.33 lakhs for Q1 FY27 (Current tax: ₹471.00 lakhs, Deferred tax credit: ₹27.67 lakhs).
  • Profit After Tax: ₹1,273.14 lakhs for Q1 FY27, compared to ₹768.18 lakhs in Q1 FY26 (65.7% increase) and ₹1,456.60 lakhs in Q4 FY26.
  • Other Comprehensive Loss: ₹1.26 lakhs for Q1 FY27 (primarily from remeasurement of defined benefit plan).
  • Total Comprehensive Income: ₹1,271.88 lakhs for Q1 FY27.

Capital Structure and Per Share Data

  • Paid-up Equity Share Capital: ₹8,205.48 lakhs (face value ₹10 per share), unchanged from previous periods.
  • Earnings Per Share (EPS):
  • Basic EPS: ₹1.55 for Q1 FY27, compared to ₹0.94 in Q1 FY26
  • Diluted EPS: ₹1.55 for Q1 FY27, compared to ₹0.94 in Q1 FY26

Regulatory and Governance Details

  • Approval Date: Board of Directors meeting held on August 3, 2026.
  • Auditor Review: Subjected to limited review by statutory auditors S.R. Batliboi & Co. LLP (ICAI Firm registration number: 301003E/E300005), who issued an unmodified conclusion.
  • Regulatory Reference: Filed under Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
  • Segment Information: Company operates in one reportable business segment - healthcare services in India.
  • Subsidiaries: The company does not have any subsidiary/associate/joint venture company as of June 30, 2026.

Comparative Figures

  • Q1 FY27 (Unaudited): June 30, 2026
  • Q4 FY26 (Audited): March 31, 2026
  • Q1 FY26 (Unaudited): June 30, 2025
  • Full Year FY26 (Audited): March 31, 2026

Additional Information

  • The figures for the quarter ended March 31, 2026, are balancing figures between audited full-year figures and previously published unaudited year-to-date figures up to December 31, 2025.
  • The financial results are available on the company's website (www.ilshospitals.com) and stock exchange websites.